8:31 AM ET
8-K
Partnership
Pluri Partnership with ZEO ScientifiX, Inc.
Pluri Inc. entered into a partnership agreement with ZEO ScientifiX to grant ZEO an exclusive license to manufacture and commercialize Pluri's regenerative medicine portfolio in the United States. In exchange, Pluri will receive a 50% equity stake in ZEO and the right to designate four out of seven board members, while ZEO will receive approximately 9% of Pluri's outstanding common shares.
- Counterparty
- ZEO ScientifiX, Inc.